PEMOLINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pemoline, and when can generic versions of Pemoline launch?
Pemoline is a drug marketed by Actavis Elizabeth, Teva Pharms, Fosun Pharma, Mallinckrodt, Vintage Pharms, and Watson Labs. and is included in eight NDAs.
The generic ingredient in PEMOLINE is pemoline. There are seven drug master file entries for this compound. Additional details are available on the pemoline profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PEMOLINE?
- What are the global sales for PEMOLINE?
- What is Average Wholesale Price for PEMOLINE?
Summary for PEMOLINE
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 8 |
| Raw Ingredient (Bulk) Api Vendors: | 45 |
| Clinical Trials: | 5 |
| Patent Applications: | 3,595 |
| DailyMed Link: | PEMOLINE at DailyMed |
Recent Clinical Trials for PEMOLINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Medical University of Vienna | Phase 2 |
| California Pacific Medical Center Research Institute | Phase 2 |
| Sheba Medical Center | N/A |
Medical Subject Heading (MeSH) Categories for PEMOLINE
Anatomical Therapeutic Chemical (ATC) Classes for PEMOLINE
US Patents and Regulatory Information for PEMOLINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Elizabeth | PEMOLINE | pemoline | TABLET, CHEWABLE;ORAL | 075678-001 | Jul 26, 2000 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | PEMOLINE | pemoline | TABLET;ORAL | 075287-001 | Jun 13, 2001 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Fosun Pharma | PEMOLINE | pemoline | TABLET;ORAL | 075286-002 | Jun 30, 1999 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Actavis Elizabeth | PEMOLINE | pemoline | TABLET;ORAL | 075595-002 | Feb 28, 2000 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Teva Pharms | PEMOLINE | pemoline | TABLET;ORAL | 075030-003 | Feb 22, 2000 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | PEMOLINE | pemoline | TABLET;ORAL | 075287-003 | Sep 18, 2000 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Fosun Pharma | PEMOLINE | pemoline | TABLET;ORAL | 075286-003 | Jun 30, 1999 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
